IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition marked by the accumulation of IgG4-positive plasma ...

A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease. The optimism stems from results presented at the ...

The trial, called AZA-PD, included 66 people with early-stage Parkinson’s disease. It investigated the effects of the drug ...